Stimcell Energetics (STME) Enterprise Value Growth (1y) (2012 - 2026)
Stimcell Energetics (STME) Enterprise Value Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -53.59% |
| Nov 30, 2025 | -36.48% |
| Aug 31, 2025 | 68.68% |
| May 31, 2025 | 66.41% |
| Feb 28, 2025 | 91.62% |
| Nov 30, 2024 | -49.50% |
| Aug 31, 2024 | 64.61% |
| May 31, 2024 | 55.83% |
| Feb 29, 2024 | -944.53% |
| Nov 30, 2023 | -27.00% |
| Aug 31, 2023 | -503.68% |
| May 31, 2023 | -303.18% |
| Feb 28, 2023 | 75.18% |
| Nov 30, 2022 | 52.05% |
| Aug 31, 2022 | 84.92% |
| May 31, 2022 | -17.48% |
| Feb 28, 2022 | -18.37% |
| Nov 30, 2021 | -70.52% |
| Aug 31, 2021 | 47.07% |
| May 31, 2021 | 53.97% |